Search the Site
Follow TheCancerLetter on Twitter
join our mailing list

Enter your name and email address to receive an update when we post new content.

IP Login

 

The Cancer Letter Inc.
PO Box 9905
Washington
DC 20016
Tel: 202-362-1809
Fax: 202-379-1787
publication date: Apr 22, 2016
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Cell Therapy Production, Patient Accrual Suspended at Rosenberg’s Lab at NCI

 

NIH has suspended the facilities that produce investigational compounds for an NCI laboratory engaged in cell therapy production and a National Institute of Mental Health facility producing positron emission tomography materials.

As a result, no new new patients will be enrolled in affected trials until the issues are resolved, NIH said in a press release.

“There is no evidence that any patients have been harmed, but a rigorous clinical review will be undertaken,” the statement reads.

The cell therapy lab is that of Steven Rosenberg, chief of the NCI Surgery Branch and one of the pioneers of immunotherapy.



To access this members-only content, please log in.

If you're not a subscriber why not join today?

If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Letter